























































































































































































































































affinityXisolated& IgGs.& The& BAH,& PH& and& PE& groups& displayed& higher& levels& of& AT1R& activating&197&
autoantibodies&compared&with&the&NT&group&(P<0.0001,&P=0.007&and&P<0.0001,&respectively)&and&198&
the&BAH&group&had&higher& functional&AT1RXAb& levels&than&the&APA&group&(P=0.01).&The&agonistic&199&




Comparison& of& AT1R& activation& in& the& cell& assay& with& the& functional& response& obtained& with&204&
angiotensin&II&in&the&doseXresponse&assay&indicated&that&the&median&AT1R&activation&achieved&with&205&























































































































































































































































































































































































































APA vs BAH APA vs PH BAH vs PH  
Age (years) 52 ± 10.2 52 ± 9.7 52 ± 19.9 0.964 N.A. N.A. N.A. 
Sex (ref. male) 21 (52.5%) 19 (47.5%) 16 (42.1%) 0.656 N.A. N.A. N.A. 
BMI (Kg/m2) 27.3 ± 4.1 26.2 ± 5.0 27.4 ± 6.0 0.500 N.A. N.A. N.A. 
Systolic BP (mmHg) 151 ± 21.5 151 ± 23.8 156 ± 17.2 0.461 N.A. N.A. N.A. 
Diastolic BP (mmHg) 93 ± 11.0 95 ± 13.6 91 ± 14.6 0.469 N.A. N.A. N.A. 
PAC (pmol/L) 569 [283-1071] 416 [311-583] 225 [128-394] < 0.001 0.742 < 0.001 0.002 
DRC (mU/L) 4.3 [2.0-11.2] 3.4 [2.0-7.3] 18.2 [8.9-45.1] < 0.001 0.831 < 0.001 < 0.001 
ARR_DRC 108 [36-306] 114 [71-162] 16 [6-26] < 0.001 1.000 < 0.001 < 0.001 
Lowest serum K+ 
(mmol/L) 

































AT1R-Ab level minus losartan  
P-value 
AT1R-Ab level plus losartan 
P-value 



















Age (years) 54 ± 14.8 55 ± 16.6  0.749 54 ± 15.5 55 ± 16.2 0.851 
Sex (ref. male) 30 (57.7) 39 (57.4) 0.970 28 (49.1) 41 (65.1) 0.077 
BMI (Kg/m2) 28.2 ± 4.7 27.5 ± 5.0 0.431 27.2 ± 4.2 28.4 ± 5.3 0.177 
Systolic BP (mmHg) 151 ± 23.9 147 ± 19.2 0.376 148 ± 25.1 149 ± 17.4 0.709 
Diastolic BP (mmHg) 92 ± 15.0 86 ± 12.5 0.018 89 ± 16.9 89 ± 10.7 0.854 
PAC (pmol/L) 235 [150-553] 300 [167-556] 0.499 236 [130-550] 286 [186-569] 0.338 
DRC (mU/L) 11.7 [5.7-31.8] 5.7 [2.2-27.0] 0.011 11.9 [5.3-39.7] 5.6 [2.3-16.3] 0.003 
ARR_DRC 23 [10-55] 47 [13-139] 0.029 19 [7-60] 49 [16-137] 0.003 
Lowest serum K+ 
(mmol/L) 


















BAH vs. APA BAH vs. PH 
OR (CI 95%) P-value OR (CI 95%) P-value 
Agonistic AT1R-Ab level - losartan     
AT1R-Abs (ref. ≥ median) 3.425 (1.342-8.696) 0.010 1.515 (0.589-3.891) 0.388 
Age (years) 0.976 (0.941-1.012) 0.186 1.025 (0.997-1.053) 0.078 
AT1R-Abs (ref. ≥ median) 3.663 (1.420-9.434) 0.007 1.495 (0.587-8.817) 0.339 
Systolic BP (mmHg) 1.019 (0.005-1.044) 0.116 0.993 (0.972-1.015) 0.532 
AT1R-Abs (ref. ≥ median) 3.521 (1.361-9.091) 0.009 1.887 (0.688-5.319) 0.231 
PAC (pmol/L) 1.001 (1.000-1.003) 0.072 1.003 (1.001-1.005) 0.003 
AT1R-Abs (ref. ≥ median) 3.546 (1.395-9.009) 0.008 1.603 (0.630-4.065) 0.322 
DRC (mU/L) 0.996 (0.989-1.004) 0.298 0.996 (0.990-1.002) 0.221 
Agonistic AT1R-Ab level + losartan     
AT1R-Abs (ref. ≥ median) 2.571 (1.027-6.452) 0.044 1.980 (0.786-5.000) 0.147 
Age (years) 0.973 (0.938-1.009) 0.135 1.026 (0.999-1.055) 0.062 
AT1R-Abs (ref. ≥ median) 2.358 (0.943-5.882) 0.066 1.832 (0.745-4.505) 0.187 
Systolic BP (mmHg) 1.015 (0.992-1.039) 0.211 0.993 (0.971-1.014) 0.497 
AT1R-Abs (ref. ≥ median) 2.381 (0.947-5.988) 0.065 2.278 (0.838-6.211) 0.107 
PAC (pmol/L) 1.001 (1.000-1.002) 0.086 1.003 (1.001-1.005) 0.003 
AT1R activation (ref. ≥ median) 2.500 (1.007-6.211) 0.048 1.698 (0.678-4.255) 0.258 



























Agonistic AT1R-Ab level - losartan    
AT1R-Abs (response ratio) 0.26 [0.23-0.29] 0.30 [0.26-0.39] 0.011 
AT1R-Abs (ref. ≥ median) 13 (37.1) 19 (76.0) 0.003 
Agonistic AT1R-Ab level + losartan    
AT1R-Abs (response ratio) 0.27 [0.20-0.30] 0.30 [0.24-0.36] 0.149 
AT1R-Abs (ref. ≥ median) 16 (45.7) 15 (60.0) 0.205 
!
Table!4.!Functional!AT1R!autoantibody!levels!stratified!by!adrenal!morphology!!
Adrenal!morphology!of!patients!with!PA!was!determined!from!CT!results!to!classify!absence!or!
presence!of!hyperplasia!in!adrenals!with!morphologic!abnormalities.!Numbers!of!patient!samples!
in!each!subgroup!are!indicated.!Affinity>purified!agonistic!AT1R>Ab!levels,!measured!with!the!cell>
based!assay,!were!treated!as!continuous!variables!and!presented!as!medians!with!lower!and!
upper!quartiles!in!parenthesis!or!categorized!as!higher!and!lower!agonistic!AT1R>Ab!levels!
according!to!the!median!value!for!patients!with!APA!and!BAH!combined!and!presented!as!
absolute!numbers!with!proportions!in!parenthesis.!P!values!designate!the!presence!of!group!
differences!by!the!Kruskal–Wallis!test!(AT1R>Ab!levels),!or!Chi!square!test!(diagnosis,!AT1R>Ab!
levels!after!categorization).!!
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